Skip to main content
Top
Published in: BMC Cardiovascular Disorders 1/2016

Open Access 01-12-2016 | Research article

Sharing success – understanding barriers and enablers to secondary prophylaxis delivery for rheumatic fever and rheumatic heart disease

Authors: Jennifer Chamberlain-Salaun, Jane Mills, Priya M. Kevat, Marc G. W. Rémond, Graeme P. Maguire

Published in: BMC Cardiovascular Disorders | Issue 1/2016

Login to get access

Abstract

Background

Rheumatic fever (RF) and rheumatic heart disease (RHD) cause considerable morbidity and mortality amongst Australian Aboriginal and Torres Strait Islander populations. Secondary antibiotic prophylaxis in the form of 4-weekly benzathine penicillin injections is the mainstay of control programs. Evidence suggests, however, that delivery rates of such prophylaxis are poor.

Methods

This qualitative study used semi-structured interviews with patients, parents/care givers and health professionals, to explore the enablers of and barriers to the uptake of secondary prophylaxis. Data from participant interviews (with 11 patients/carers and 11 health practitioners) conducted in four far north Queensland sites were analyzed using the method of constant comparative analysis.

Results

Deficits in registration and recall systems and pain attributed to injections were identified as barriers to secondary prophylaxis uptake. There were also varying perceptions regarding responsibility for ensuring injection delivery. Enablers of secondary prophylaxis uptake included positive patient-healthcare provider relationships, supporting patient autonomy, education of patients, care givers and healthcare providers, and community-based service delivery.

Conclusion

The study findings provide insights that may facilitate enhancement of secondary prophylaxis delivery systems and thereby improve uptake of secondary prophylaxis for RF/RHD.
Literature
1.
go back to reference RHDAustralia (ARF/RHD writing group), National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand. Australian guideline for prevention, diagnosis and management of acute rheumatic fever and rheumatic heart disease (2nd edition). 2012. RHDAustralia (ARF/RHD writing group), National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand. Australian guideline for prevention, diagnosis and management of acute rheumatic fever and rheumatic heart disease (2nd edition). 2012.
2.
go back to reference Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis. 2005;5(11):685–94.CrossRefPubMed Carapetis JR, Steer AC, Mulholland EK, Weber M. The global burden of group A streptococcal diseases. Lancet Infect Dis. 2005;5(11):685–94.CrossRefPubMed
3.
4.
go back to reference AIHW, Field B. Rheumatic heart disease: all but forgotten except among Aboriginal and Torres Strait Islander peoples. Canberra: Australian Institute of Health and Welfare; 2004. Bulletin no. 16. AIHW Cat. No. AUS 48. AIHW, Field B. Rheumatic heart disease: all but forgotten except among Aboriginal and Torres Strait Islander peoples. Canberra: Australian Institute of Health and Welfare; 2004. Bulletin no. 16. AIHW Cat. No. AUS 48.
5.
go back to reference Carapetis JR, Currie BJ. Mortality due to acute rheumatic fever and rheumatic heart disease in the Northern Territory: a preventable cause of death in aboriginal people. Aust N Z J Public Health. 1999;23(2):159–63.CrossRefPubMed Carapetis JR, Currie BJ. Mortality due to acute rheumatic fever and rheumatic heart disease in the Northern Territory: a preventable cause of death in aboriginal people. Aust N Z J Public Health. 1999;23(2):159–63.CrossRefPubMed
6.
go back to reference Carapetis JR, Wolff DR, Currie BJ. Acute rheumatic fever and rheumatic heart disease in the top end of Australia’s Northern Territory. Med J Aust. 1996;164(3):146–9.PubMed Carapetis JR, Wolff DR, Currie BJ. Acute rheumatic fever and rheumatic heart disease in the top end of Australia’s Northern Territory. Med J Aust. 1996;164(3):146–9.PubMed
7.
go back to reference Meira ZM, Goulart EM, Colosimo EA, Mota CC. Long term follow up of rheumatic fever and predictors of severe rheumatic valvar disease in Brazilian children and adolescents. Heart. 2005;91(8):1019–22.CrossRefPubMedPubMedCentral Meira ZM, Goulart EM, Colosimo EA, Mota CC. Long term follow up of rheumatic fever and predictors of severe rheumatic valvar disease in Brazilian children and adolescents. Heart. 2005;91(8):1019–22.CrossRefPubMedPubMedCentral
8.
go back to reference Carapetis JR, Kilburn CJ, MacDonald KT, Walker AR, Currie BJ. Ten-year follow up of a cohort with rheumatic heart disease (RHD). Aust N Z J Med. 1997;27(6):691–7.CrossRefPubMed Carapetis JR, Kilburn CJ, MacDonald KT, Walker AR, Currie BJ. Ten-year follow up of a cohort with rheumatic heart disease (RHD). Aust N Z J Med. 1997;27(6):691–7.CrossRefPubMed
9.
go back to reference Expert consultation on rheumatic fever and rheumatic heart disease. Report of a WHO expert consultation on rheumatic fever and rheumatic heart disease 29 October–1 November 2001. Geneva: World Health Organisation; 2001. Expert consultation on rheumatic fever and rheumatic heart disease. Report of a WHO expert consultation on rheumatic fever and rheumatic heart disease 29 October–1 November 2001. Geneva: World Health Organisation; 2001.
10.
go back to reference Manyemba J, Mayosi BM. Penicillin for secondary prevention of rheumatic fever. Cochrane Database Syst Rev. 2002;3, CD002227. Manyemba J, Mayosi BM. Penicillin for secondary prevention of rheumatic fever. Cochrane Database Syst Rev. 2002;3, CD002227.
11.
go back to reference World Health Organization. Rheumatic fever and rheumatic heart disease: report of a WHO expert consultation, Geneva, 29 October - 1 November 2001. WHO technical report series 923. 2004. World Health Organization. Rheumatic fever and rheumatic heart disease: report of a WHO expert consultation, Geneva, 29 October - 1 November 2001. WHO technical report series 923. 2004.
12.
go back to reference Remond M, Coyle M, Mills J, Maguire G. Approaches to improving adherence to secondary prophylaxis for rheumatic fever and rheumatic heart disease: a literature review with a global perspective. Cardiol Rev. 2016;24(2):94–8.CrossRefPubMed Remond M, Coyle M, Mills J, Maguire G. Approaches to improving adherence to secondary prophylaxis for rheumatic fever and rheumatic heart disease: a literature review with a global perspective. Cardiol Rev. 2016;24(2):94–8.CrossRefPubMed
13.
go back to reference Remond M, Severin K, Hodder Y, Martin J, Nelson C, Atkinson D, et al. Variability in disease burden and management of rheumatic fever and rheumatic heart disease in two regions of tropical Australia. Intern Med J. 2013;43(4):386–93.CrossRefPubMed Remond M, Severin K, Hodder Y, Martin J, Nelson C, Atkinson D, et al. Variability in disease burden and management of rheumatic fever and rheumatic heart disease in two regions of tropical Australia. Intern Med J. 2013;43(4):386–93.CrossRefPubMed
14.
go back to reference Remond M, Wheaton G, Walsh W, Prior D, Maguire G. Acute rheumatic fever and rheumatic heart disease-priorities in prevention, diagnosis and management. A report of the CSANZ Indigenous Cardiovascular Health Conference, Alice Springs 2011. Heart Lung Circ. 2012;21(10):632–8.CrossRefPubMed Remond M, Wheaton G, Walsh W, Prior D, Maguire G. Acute rheumatic fever and rheumatic heart disease-priorities in prevention, diagnosis and management. A report of the CSANZ Indigenous Cardiovascular Health Conference, Alice Springs 2011. Heart Lung Circ. 2012;21(10):632–8.CrossRefPubMed
15.
17.
go back to reference Elissa S, Lee R, Binns P, Garstone G, McDonald M. Assessment of a register-based rheumatic heart disease secondary prevention program in an Australian Aboriginal community. Aust N Z J Public Health. 2005;29(6):521–5.CrossRef Elissa S, Lee R, Binns P, Garstone G, McDonald M. Assessment of a register-based rheumatic heart disease secondary prevention program in an Australian Aboriginal community. Aust N Z J Public Health. 2005;29(6):521–5.CrossRef
18.
go back to reference Mills J, Birks M. Qualitative methodology: a practical guide. London: SAGE Publications Ltd.; 2014. Mills J, Birks M. Qualitative methodology: a practical guide. London: SAGE Publications Ltd.; 2014.
19.
go back to reference Wagner EH, Austin BT, Davis C, Hindmarsh M, Schaefer J, Bonomi A. Improving chronic illness care: translating evidence into action. Health Aff (Millwood). 2001;20(6):64–78.CrossRef Wagner EH, Austin BT, Davis C, Hindmarsh M, Schaefer J, Bonomi A. Improving chronic illness care: translating evidence into action. Health Aff (Millwood). 2001;20(6):64–78.CrossRef
21.
go back to reference Harrington Z, Thomas DP, Currie BJ, Bulkanhawuy J. Challenging perceptions of non-compliance with rheumatic fever prophylaxis in a remote Aboriginal community. Med J Aust. 2006;184(10):514–7.PubMed Harrington Z, Thomas DP, Currie BJ, Bulkanhawuy J. Challenging perceptions of non-compliance with rheumatic fever prophylaxis in a remote Aboriginal community. Med J Aust. 2006;184(10):514–7.PubMed
22.
go back to reference Amir J, Ginat S, Cohen YH, Marcus TE, Keller N, Varsano I. Lidocaine as a diluent for administration of benzathine penicillin G. Pediatr Infect Dis J. 1998;17(10):890–3.CrossRefPubMed Amir J, Ginat S, Cohen YH, Marcus TE, Keller N, Varsano I. Lidocaine as a diluent for administration of benzathine penicillin G. Pediatr Infect Dis J. 1998;17(10):890–3.CrossRefPubMed
23.
go back to reference Russell K, Nicholson R, Naidu R. Reducing the pain of intramuscular benzathine penicillin injections in the rheumatic fever population of Counties Manukau District Health Board. J Paediatr Child Health. 2014;50(2):112–7.CrossRefPubMed Russell K, Nicholson R, Naidu R. Reducing the pain of intramuscular benzathine penicillin injections in the rheumatic fever population of Counties Manukau District Health Board. J Paediatr Child Health. 2014;50(2):112–7.CrossRefPubMed
24.
go back to reference Weinstein P, Raadal M, Naidu S, Yoshida T, Kvale G, Milgrom P. A videotaped intervention to enhance child control and reduce anxiety of the pain of dental injections. Eur J Paediatr Dent. 2003;4(4):181–5.PubMed Weinstein P, Raadal M, Naidu S, Yoshida T, Kvale G, Milgrom P. A videotaped intervention to enhance child control and reduce anxiety of the pain of dental injections. Eur J Paediatr Dent. 2003;4(4):181–5.PubMed
25.
go back to reference White H, Walsh W, Brown A, Riddell T, Tonkin A, Jeremy R, et al. Rheumatic heart disease in Indigenous populations. Heart Lung Circ. 2010;19:273–81.CrossRefPubMed White H, Walsh W, Brown A, Riddell T, Tonkin A, Jeremy R, et al. Rheumatic heart disease in Indigenous populations. Heart Lung Circ. 2010;19:273–81.CrossRefPubMed
26.
go back to reference Chandler M, Lalonde C. Cultural continuity as a protective factor against suicide in First Nations youth. Horizons --A Special Issue on Aboriginal Youth, Hope or Heartbreak: Aboriginal Youth and Canada’s Future. 2008;10(1):68–72. Chandler M, Lalonde C. Cultural continuity as a protective factor against suicide in First Nations youth. Horizons --A Special Issue on Aboriginal Youth, Hope or Heartbreak: Aboriginal Youth and Canada’s Future. 2008;10(1):68–72.
27.
go back to reference Grayson S, Horsburgh M, Lennon D. An Auckland regional audit of the nurse-led rheumatic fever secondary prophylaxis programme. N Z Med J. 2006;119(1243):U2255.PubMed Grayson S, Horsburgh M, Lennon D. An Auckland regional audit of the nurse-led rheumatic fever secondary prophylaxis programme. N Z Med J. 2006;119(1243):U2255.PubMed
28.
go back to reference International Rheumatic Fever Study Group. Allergic reactions to long-term benzathine penicillin prophylaxis for rheumatic fever. Lancet. 1991;337(8753):1308–10. International Rheumatic Fever Study Group. Allergic reactions to long-term benzathine penicillin prophylaxis for rheumatic fever. Lancet. 1991;337(8753):1308–10.
Metadata
Title
Sharing success – understanding barriers and enablers to secondary prophylaxis delivery for rheumatic fever and rheumatic heart disease
Authors
Jennifer Chamberlain-Salaun
Jane Mills
Priya M. Kevat
Marc G. W. Rémond
Graeme P. Maguire
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Cardiovascular Disorders / Issue 1/2016
Electronic ISSN: 1471-2261
DOI
https://doi.org/10.1186/s12872-016-0344-x

Other articles of this Issue 1/2016

BMC Cardiovascular Disorders 1/2016 Go to the issue